Navigation Links
Chronic GI Troubles Keep Workers Off the Job
Date:10/16/2007

They lose one day a week on average, study finds

TUESDAY, Oct. 16 (HealthDay News) -- People with some common functional gastrointestinal disorders lose the equivalent of at least one full day of work in every 40-hour workweek, a new U.S. study finds.

Functional gastrointestinal disorders, which are associated with impaired quality of life, are among the most common causes of workplace-related absenteeism. These conditions also play a role in "presenteeism" -- when people go to work but are less productive than normal.

For the study, patients filled out numerous questionnaires over one year. People with irritable bowel syndrome with constipation (IBS-C), chronic constipation (CC) alone, or functional dyspepsia (FD) lost 10.3 hours of work per week, while those with gastroesophageal reflux disease (GERD) lost about 6.3 hours per week.

Patients with IBS-C, chronic constipation and functional dyspepsia (chronic or recurrent pain or discomfort in the upper abdomen, including feeling full earlier than expected when eating, sometimes accompanied by bloating, belching, nausea or heartburn) also scored higher on a scale measuring impairment/productivity loss than GERD patients.

"This research demonstrates the significant economic impact of these common conditions," study author Dr. G. Richard Locke, of the Mayo Clinic College of Medicine, said in a prepared statement. He conducted the research along with co-investigators from drug maker Novartis Pharmaceuticals.

The findings were slated for presentation Monday at the American College of Gastroenterology annual meeting in Philadelphia.

More information

The American College of Gastroenterology has more about common GI problems.



-- Robert Preidt



SOURCE: American College of Gastroenterology, news release, Oct. 15, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Roller coasters – cause “Chronic Headache?
2. TIZANIDINE - New solution to chronic headache
3. Analgesic abuse - cause for chronic headache in children
4. New Treatment for Chronic Hepatitis B
5. Hyperflexible joints connected to chronic fatigue
6. In Chronic Diseases - Poor compliance of Patients with drug treatment
7. New Treatment for Chronic Eczema
8. Novel Therapy for Chronic Problem
9. Overcoming Chronic Fatigue
10. Chronic Fatigue, Pain Linked to Sinusitis
11. Chronic Diseases said to Cause Falls in the Elderly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... Earlier this month, the ... use of health IT to create efficiencies in healthcare information exchange and a trusted ... 2017 Summer Forum which featured keynote addresses by Donald W. Rucker, MD, head ...
(Date:8/23/2017)... Ogden, Utah (PRWEB) , ... August 23, 2017 , ... ... 2013. , Give Back Day is a time Nightingale College dedicates to serving ... with organizations that thrive on donations and volunteers or those that need a little ...
(Date:8/23/2017)... ... August 23, 2017 , ... Boling Vision ... home to Indiana, and is now seeing patients at Boling Vision Center’s Elkhart ... in the diagnosis and treatment of eye disease, medical retina, high-technology cataract surgery, ...
(Date:8/23/2017)... ... August 23, 2017 , ... TSC Advantage ... - for Risk Management Solution Innovations and Security Solution for Government Innovations. Both ... in 2017 and its DHS SAFETY Act-designated enterprise security assessment approach. , The ...
(Date:8/22/2017)... ... August 22, 2017 , ... The Women’s Choice Award, a growing ... Relief with the 2017 Women’s Choice Award. The identification by women of an ... of 4 migraine sufferers are women. In a survey taken by the Women’s Choice ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of the drug ... in the beginning stages of an IPO. The ... with the average cost of a prescription epilepsy drug being $450.00-$1200.00 for ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: ... immunology, today reports its financial results for the second ... achievements during the second quarter 2017 and to date: ... multiple clinical development programs for the Company,s lead project, ... 3 pivotal study with BL-8040 as novel stem cell ...
Breaking Medicine Technology: